Defactinib (PF-04554878) |
|
Synonyms: PF-4554878, VS-6063;N-methyl-4-((4-(((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide | |
Cat. No.: D15900 | CAS No.: 1073154-85-4 |
MDL.: | Formula: C20H21F3N8O3S |
F.W.510.49 | Purity: 99% |
Storage: | |
  |
Catalog Number: | D15900 | CAS No.: | 1073154-85-4 | |
MDL: | Formula: | C20H21F3N8O3S | ||
F.W.: | 510.49 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | M.P.: | |||
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | DMSO | Stability: | ||
Storage: | Category: | Reference Standard | ||
Application: | PF-04554878 is a novel FAK kinase inhibitor that decreases growth and induces apoptosis in pancreatic neuroendocrine tumor cells |